Mistletoe’s Fraxini Powerful Enough to Fight Colon Cancer

.

Mistletoe’s Fraxini Powerful Enough to Fight Colon Cancer

Mistletoe would be likely bought by many as the occasion of Christmas is ahead. It is being said by a team of researchers that the plant used to celebrate the festival has proved promising as a treatment for colon cancer.

This particular form of cancer is known as a second leading cause of deaths related to cancers in the western areas. In Australia, some 80 people die of the same each year. Therefore, say experts, it is highly essential to address the disease sooner as possible.

A study was conducted by the team from the University of Adelaide, which involved testing of fraxini, a type of mistletoe. It was found that the plants had more potential in curing the colon cancer as compared to chemotherapy.

It is being said that though distinct kinds of extracts of mistletoe are in use in varied European countries. But, Australia is new to the same. The fraxini plant has a protein that can kill rapidly dividing cancer cells. And during the same, it remains soothing on intestinal cells.

"This might mean that Fraxini is a potential candidate for increased toxicity against cancer, while also reducing potential side effects", said Zahra Lotfollahi, a health sciences honors student.


Latest News

Charges dropped against three officials in Freddie Gray case
Reagan shooter to be released from a Washington psychiatric hospital
Trump Claims He has No Interest in Russia
Facebook’s Second Quarter Earnings Beat Expectations; Share Prices Soar
Fed Signals Gradual Rate Hike; Asian Currencies Won and Ringgit Gain on Weaker D
Sanders urge supporters to back Clinton
Young boy’s Prosthetic Leg stolen in Orange County on Sunday
McDonald’s Turnaround Effort Stumbles as All-Day Breakfast Seems to Lose Popular
Apple Inc’s Revenue Drops for the Second Consecutive Quarer on iPhone Slump
Two killed in gunfire at nightclub in Fort Myers in Florida
Federal judge to consider Volkswagen’s $15 billion settlement
Demand for Treasury’s Auction Weak as Traders Expect an Interest Hike this Year